Product Information
LOJAIMIESS 0.1-0.02-0.01 TAB is a generic product labeled by Xiromed LLC, priced at $0.2395 per EA under NDC 70700012487. Its NADAC has been published 336 times since Mar 18, 2020.
FDA first approved this application on Dec 14, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700012487
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205131FDA Approved
12/14/2017
TE Code
AB
On Market Since
2/11/2019
Price Statistics
The NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has been published 336 times since Mar 18, 2020, and over the history we have for it it has declined 35.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2395 per EA |
|---|---|
| All-time high | $0.4996 (Aug 12, 2020) |
| All-time low | $0.1337 (Jul 17, 2024) |
| 52-week high | $0.2436 |
| 52-week low | $0.1911 |
| Median price | $0.2710 |
| Average price | $0.2762 |
| Largest weekly change | +86.4% (Nov 22, 2023) |
| Weeks tracked | 336 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levonorgestrel/ethinyl estradiol and ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOJAIMIESS 0.1-0.02-0.01 TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOJAIMIESS 0.1-0.02-0.01 TAB, manufactured by Xiromed LLC, is $0.2395 per EA (NDC 70700012487), effective Aug 19, 2026.
How has the price of LOJAIMIESS 0.1-0.02-0.01 TAB changed over time?
Over the history we have for it, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has declined 35.2%. It has been tracked across 336 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for LOJAIMIESS 0.1-0.02-0.01 TAB?
Since Mar 18, 2020, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has ranged from a low of $0.1337 (Jul 17, 2024) to a high of $0.4996 (Aug 12, 2020), with a median of $0.2710 per EA.
Are there cheaper alternatives to LOJAIMIESS 0.1-0.02-0.01 TAB?
No other NADAC-published product currently shares the active ingredient and strength of LOJAIMIESS 0.1-0.02-0.01 TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOJAIMIESS 0.1-0.02-0.01 TAB?
LOJAIMIESS 0.1-0.02-0.01 TAB (NDC 70700012487) is labeled by Xiromed LLC, and CMS classifies it as a generic product.